Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 190

1.

Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment.

Muñoz-Lopetegi A, de Bruijn MAAM, Boukhrissi S, Bastiaansen AEM, Nagtzaam MMP, Hulsenboom ESP, Boon AJW, Neuteboom RF, de Vries JM, Sillevis Smitt PAE, Schreurs MWJ, Titulaer MJ.

Neurol Neuroimmunol Neuroinflamm. 2020 Mar 2;7(3). pii: e696. doi: 10.1212/NXI.0000000000000696. Print 2020 May.

2.

Pediatric autoimmune encephalitis: Recognition and diagnosis.

de Bruijn MAAM, Bruijstens AL, Bastiaansen AEM, van Sonderen A, Schreurs MWJ, Sillevis Smitt PAE, Hintzen RQ, Neuteboom RF, Titulaer MJ; CHANCE Study Group.

Neurol Neuroimmunol Neuroinflamm. 2020 Feb 11;7(3). pii: e682. doi: 10.1212/NXI.0000000000000682. Print 2020 May.

3.

Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: An investigation at the protein level.

Dekker LJM, Wu S, Jurriëns C, Mustafa DAN, Grevers F, Burgers PC, Sillevis Smitt PAE, Kros JM, Luider TM.

FASEB J. 2020 Mar;34(3):3646-3657. doi: 10.1096/fj.201902352R. Epub 2020 Jan 20.

PMID:
31960518
4.

Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigens.

Weenink B, Draaisma K, Ooi HZ, Kros JM, Sillevis Smitt PAE, Debets R, French PJ.

Sci Rep. 2019 Oct 10;9(1):14643. doi: 10.1038/s41598-019-51063-6.

5.

Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patients.

Weenink B, van Brakel M, Wijers R, Sillevis Smitt PAE, French PJ, Debets R.

J Neurooncol. 2019 Aug;144(1):79-87. doi: 10.1007/s11060-019-03228-6. Epub 2019 Jun 25.

6.

The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies.

van Coevorden-Hameete MH, de Bruijn MAAM, de Graaff E, Bastiaansen DAEM, Schreurs MWJ, Demmers JAA, Ramberger M, Hulsenboom ESP, Nagtzaam MMP, Boukhrissi S, Veldink JH, Verschuuren JJGM, Hoogenraad CC, Sillevis Smitt PAE, Titulaer MJ.

Brain. 2019 Jun 1;142(6):1631-1643. doi: 10.1093/brain/awz094.

7.

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis.

de Bruijn MAAM, van Sonderen A, van Coevorden-Hameete MH, Bastiaansen AEM, Schreurs MWJ, Rouhl RPW, van Donselaar CA, Majoie MHJM, Neuteboom RF, Sillevis Smitt PAE, Thijs RD, Titulaer MJ.

Neurology. 2019 May 7;92(19):e2185-e2196. doi: 10.1212/WNL.0000000000007475. Epub 2019 Apr 12.

8.

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer.

Rodríguez-Blanco G, Zeneyedpour L, Duijvesz D, Hoogland AM, Verhoef EI, Kweldam CF, Burgers PC, Smitt PS, Bangma CH, Jenster G, van Leenders GJLH, Dekker LJM, Luider TM.

Oncotarget. 2018 Nov 23;9(92):36444-36456. doi: 10.18632/oncotarget.26342. eCollection 2018 Nov 23.

9.

Opioid responsiveness of nociceptive versus mixed pain in clinical cancer patients.

Bechakra M, Moerdijk F, van Rosmalen J, Koch BCP, van der Rijt CCD, Sillevis Smitt PAE, Jongen JLM.

Eur J Cancer. 2018 Dec;105:79-87. doi: 10.1016/j.ejca.2018.09.036. Epub 2018 Nov 12.

PMID:
30439627
10.

Novel methods to diagnose leptomeningeal metastases in breast cancer.

Angus L, Martens JWM, van den Bent MJ, Sillevis Smitt PAE, Sleijfer S, Jager A.

Neuro Oncol. 2019 Mar 18;21(4):428-439. doi: 10.1093/neuonc/noy186.

11.

Predictive value of electroencephalography in anti-NMDA receptor encephalitis.

Sonderen AV, Arends S, Tavy DLJ, Bastiaansen AEM, Bruijn MAAM, Schreurs MWJ, Sillevis Smitt PAE, Titulaer MJ.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1101-1106. doi: 10.1136/jnnp-2018-318376. Epub 2018 Aug 22.

PMID:
30135187
12.

IDH1-mutated transgenic zebrafish lines: An in-vivo model for drug screening and functional analysis.

Gao Y, de Wit M, Struys EA, van der Linde HCZ, Salomons GS, Lamfers MLM, Willemsen R, Sillevis Smitt PAE, French PJ.

PLoS One. 2018 Jun 28;13(6):e0199737. doi: 10.1371/journal.pone.0199737. eCollection 2018.

13.

Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis.

de Bruijn MAAM, Aarsen FK, van Oosterhout MP, van der Knoop MM, Catsman-Berrevoets CE, Schreurs MWJ, Bastiaansen DEM, Sillevis Smitt PAE, Neuteboom RF, Titulaer MJ; CHANCE Study Group.

Neurology. 2018 May 29;90(22):e1997-e2005. doi: 10.1212/WNL.0000000000005605. Epub 2018 Apr 27.

14.

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial.

Gao Y, Weenink B, van den Bent MJ, Erdem-Eraslan L, Kros JM, Sillevis Smitt P, Hoang-Xuan K, Brandes AA, Vos M, Dhermain F, Enting R, Ryan GF, Chinot O, Ben Hassel M, van Linde ME, Mason WP, Gijtenbeek JMM, Balana C, von Deimling A, Gorlia T, Stupp R, Hegi ME, Baumert BG, French PJ.

Eur J Cancer. 2018 May;94:168-178. doi: 10.1016/j.ejca.2018.02.023. Epub 2018 Mar 20.

PMID:
29571083
15.

Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium.

GLASS Consortium.

Neuro Oncol. 2018 Jun 18;20(7):873-884. doi: 10.1093/neuonc/noy020. Review.

16.

Immune Repertoire after Immunization As Seen by Next-Generation Sequencing and Proteomics.

VanDuijn MM, Dekker LJ, van IJcken WFJ, Sillevis Smitt PAE, Luider TM.

Front Immunol. 2017 Oct 16;8:1286. doi: 10.3389/fimmu.2017.01286. eCollection 2017.

17.

Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes.

van Coevorden-Hameete MH, van Beuningen SFB, Perrenoud M, Will LM, Hulsenboom E, Demonet JF, Sabater L, Kros JM, Verschuuren JJGM, Titulaer MJ, de Graaff E, Sillevis Smitt PAE, Hoogenraad CC.

Ann Clin Transl Neurol. 2017 Jul 28;4(9):680-686. doi: 10.1002/acn3.396. eCollection 2017 Sep.

18.

Advanced cancer pain: the search for genetic factors correlated with interindividual variability in opioid requirement.

Matic M, Jongen JL, Elens L, de Wildt SN, Tibboel D, Sillevis Smitt PA, van Schaik RH.

Pharmacogenomics. 2017 Aug;18(12):1133-1142. doi: 10.2217/pgs-2017-0060. Epub 2017 Jul 26.

PMID:
28745577
19.

Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options.

Yadak R, Sillevis Smitt P, van Gisbergen MW, van Til NP, de Coo IF.

Front Cell Neurosci. 2017 Feb 15;11:31. doi: 10.3389/fncel.2017.00031. eCollection 2017. Review.

20.

Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4.

van Sonderen A, Roelen DL, Stoop JA, Verdijk RM, Haasnoot GW, Thijs RD, Wirtz PW, Schreurs MW, Claas FH, Sillevis Smitt PA, Titulaer MJ.

Ann Neurol. 2017 Feb;81(2):193-198. doi: 10.1002/ana.24858. Epub 2017 Jan 27.

PMID:
28026046

Supplemental Content

Loading ...
Support Center